Correlations between bone turnover markers, serum magnesium and bone mass density in postmenopausal osteoporosis

Osteoporosis

Denosumab effects on bone density and turnover in postmenopausal women with low bone mass with or without previous treatment

Bone.

Tsourdi E, Makras P, Rachner TD, Polyzos S, Rauner M, Mandanas S, Hofbauer LC, Anastasilakis AD

doi: 10.1016/j.bone.

COMMENTED

Osteoporosis

Effects of discontinuing oral bisphosphonate treatments for postmenopausal osteoporosis on bone turnover markers and bone density

Osteoporos Int.

Naylor KE, Bradburn M, Paggiosi MA, Gossiel F, Peel NFA, McCloskey EV, Walsh JS, Eastell R

doi: 10.1007/s00198-018-4460-6.

Rheumatoid Arthritis

Dickkopf-1 (Dkk-1) serum levels in systemic sclerosis and rheumatoid arthritis patients: correlation with the Trabecular Bone Score (TBS)

Clin Rheumatol.

Ruaro B, Casabella A, Paolino S, Pizzorni C, Ghio M, Seriolo C, Molfetta L, Odetti P, Smith V, Cutolo M

doi: 10.1007/s10067-

Osteoporosis

Treatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women: A Clinical Practice Guideline Update From the American College of Physicians

Ann Intern Med.

Qaseem A, Forciea MA, McLean RM, Denberg TD; Clinical Guidelines Committee of the American College of Physicians

doi: 10.7326/M15-1361.

Osteoporosis

Trabecular bone microarchitecture predicts fragility fractures in postmenopausal women on denosumab treatment

Bone.

Butscheidt S, Rolvien T, Vettorazzi E, Frieling I

doi: 10.1016/j.bone.2018.06.022.

Osteoporosis

Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study

Lancet Diabetes Endocrinol.

McClung MR, O'Donoghue ML, Papapoulos SE, Bone H, Langdahl B, Saag KG, Reid IR, Kiel DP, Cavallari I, Bonaca MP, Wiviott SD, de Villiers T, Ling X, Lippuner K, Nakamura T, Reginster JY, Rodriguez-Portales JA, Roux C, Zanchetta J, Zerbini CAF, Park JG, Im K, Cange A, Grip LT, Heyden N, DaSilva C, Cohn D, Massaad R, Scott BB, Verbruggen N, Gurner D, Miller DL, Blair ML, Polis AB, Stoch SA, Santora A, Lombardi A, Leung AT, Kaufman KD, Sabatine MS, LOFT Investigators.

doi: 10.1016/S2213-8587(19)30346-8.

OsteoporosisRheumatoid Arthritis

Autoantibodies to Osteoprotegerin are Associated with Low Hip Bone Mineral Density and History of Fractures in Axial Spondyloarthritis: A Cross-Sectional Observational Study

Calcif Tissue Int.

Hauser B, Zhao S, Visconti MR, Riches PL, Fraser WD, Piec I, Goodson NJ, Ralston SH

doi: 10.1007/s00223-017-0291-2.

Osteoporosis

European guidance for the diagnosis and management of osteoporosis in postmenopausal women

Osteoporos Int.

Kanis JA, Cooper C, Rizzoli R, Reginster JY, Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis (ESCEO) and the Committees of Scientific Advisors and National Societies of the International Osteoporosis Foundation (IOF)

doi: 10.1007/s00198-

Osteoporosis

Abaloparatide for the treatment of postmenopausal osteoporosis

Drugs Today (Barc).

Pietrogrande L, Raimondo E

doi: 10.1358/

Related content

Denosumab effects on bone density and turnover in postmenopausal women with low bone mass with or without previous treatment

Effects of discontinuing oral bisphosphonate treatments for postmenopausal osteoporosis on bone turnover markers and bone density

Dickkopf-1 (Dkk-1) serum levels in systemic sclerosis and rheumatoid arthritis patients: correlation with the Trabecular Bone Score (TBS)

Treatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women: A Clinical Practice Guideline Update From the American College of Physicians

Trabecular bone microarchitecture predicts fragility fractures in postmenopausal women on denosumab treatment

Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study

Autoantibodies to Osteoprotegerin are Associated with Low Hip Bone Mineral Density and History of Fractures in Axial Spondyloarthritis: A Cross-Sectional Observational Study

European guidance for the diagnosis and management of osteoporosis in postmenopausal women

Abaloparatide for the treatment of postmenopausal osteoporosis